Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Expanded Access Trial of Belimumab Antibody (Monoclonal Anti-BLyS Antibody) in Patients With Rheumatoid Arthritis (RA) Who Were Previously Treated Under HGS Protocol LBRA99

NCT00931086 is registered in ClinicalTrials.gov with Human Genome Sciences Inc., a GSK Company as lead sponsor.

NCT NCT00931086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00931086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Expanded Access Trial of Belimumab Antibody (Monoclonal Anti-BLyS Antibody) in Patients With Rheumatoid Arthritis (RA) Who Were Previously Treated Under HGS Protocol LBRA99
Lead sponsor
Human Genome Sciences Inc., a GSK Company
Phase
Expanded access
Overall status
No longer available
Start date
April 30, 2009
Completion date
December 31, 2011
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis